Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $334.15 | 4 | 93.9% |
| Education | $21.70 | 1 | 6.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Medtronic, Inc. | $135.11 | 1 | $0 (2023) |
| PFIZER INC. | $92.95 | 1 | $0 (2018) |
| Boston Scientific Corporation | $88.65 | 1 | $0 (2020) |
| Merck Sharp & Dohme LLC | $21.70 | 1 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $17.44 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $135.11 | 1 | Medtronic, Inc. ($135.11) |
| 2022 | $21.70 | 1 | Merck Sharp & Dohme LLC ($21.70) |
| 2020 | $88.65 | 1 | Boston Scientific Corporation ($88.65) |
| 2018 | $110.39 | 2 | PFIZER INC. ($92.95) |
All Payment Transactions
5 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/18/2023 | Medtronic, Inc. | MICRA (Device) | Food and Beverage | In-kind items and services | $135.11 | General |
| Category: Pacemakers | ||||||
| 08/01/2022 | Merck Sharp & Dohme LLC | VERQUVO (Drug) | Education | In-kind items and services | $21.70 | General |
| Category: CARDIOVASCULAR | ||||||
| 03/09/2020 | Boston Scientific Corporation | WATCHMAN (Device) | Food and Beverage | In-kind items and services | $88.65 | General |
| Category: STRUCTURAL HEART | ||||||
| 11/14/2018 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $92.95 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 06/20/2018 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $17.44 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 1,285 | 1,791 | $769,365 | $172,246 |
| 2022 | 20 | 1,411 | 1,976 | $779,448 | $181,180 |
| 2021 | 19 | 1,375 | 1,909 | $721,342 | $172,520 |
| 2020 | 20 | 1,402 | 1,825 | $689,772 | $145,815 |
All Medicare Procedures & Services
78 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 302 | 303 | $322,280 | $45,342 | 14.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 261 | 444 | $118,992 | $42,256 | 35.5% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 71 | 71 | $87,614 | $26,622 | 30.4% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2023 | 72 | 144 | $65,136 | $13,623 | 20.9% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 57 | 113 | $29,832 | $11,207 | 37.6% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 52 | 208 | $22,672 | $8,451 | 37.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 26 | 32 | $11,520 | $4,691 | 40.7% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 82 | 83 | $33,947 | $4,386 | 12.9% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 27 | 28 | $9,324 | $3,038 | 32.6% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 18 | 18 | $10,854 | $2,823 | 26.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 208 | 238 | $21,420 | $2,724 | 12.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 16 | 16 | $6,640 | $1,970 | 29.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 13 | 13 | $6,344 | $1,879 | 29.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 17 | 17 | $4,624 | $1,522 | 32.9% |
| 93224 | Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | Office | 2023 | 29 | 29 | $14,848 | $1,484 | 10.0% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 34 | 34 | $3,318 | $226.05 | 6.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 282 | 474 | $127,032 | $45,131 | 35.5% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2022 | 240 | 242 | $257,730 | $39,034 | 15.1% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2022 | 73 | 73 | $90,082 | $28,900 | 32.1% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2022 | 72 | 144 | $52,560 | $14,398 | 27.4% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 60 | 127 | $33,528 | $10,838 | 32.3% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2022 | 54 | 216 | $23,544 | $10,475 | 44.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 55 | 89 | $16,376 | $5,336 | 32.6% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 44 | 46 | $15,318 | $5,119 | 33.4% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2022 | 77 | 77 | $31,493 | $4,148 | 13.2% |
About Dr. Andrew Beck, M.D
Dr. Andrew Beck, M.D is a Cardiovascular Disease healthcare provider based in Trumbull, Connecticut. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/25/2012. The National Provider Identifier (NPI) number assigned to this provider is 1467710657.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Andrew Beck, M.D has received a total of $355.85 in payments from pharmaceutical and medical device companies, with $135.11 received in 2023. These payments were reported across 5 transactions from 5 companies. The most common payment nature is "Food and Beverage" ($334.15).
As a Medicare-enrolled provider, Beck has provided services to 5,473 Medicare beneficiaries, totaling 7,501 services with total Medicare billing of $671,760. Data is available for 4 years (2020–2023), covering 78 distinct procedure/service records.
Practice Information
- Specialty Cardiovascular Disease
- Location Trumbull, CT
- Active Since 04/25/2012
- Last Updated 03/19/2019
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1467710657
Products in Payments
- MICRA (Device) $135.11
- ELIQUIS (Drug) $92.95
- WATCHMAN (Device) $88.65
- VERQUVO (Drug) $21.70
- BRILINTA (Drug) $17.44
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Trumbull
Dr. Manuel Pun, Md, MD
Cardiovascular Disease — Payments: $43,941
Dr. Robert Jumper, Md, MD
Cardiovascular Disease — Payments: $15,657
David Lorenz, M.d, M.D
Cardiovascular Disease — Payments: $15,579
Dr. Charles Landau, Md, MD
Cardiovascular Disease — Payments: $7,204
Victor Mejia, M.d, M.D
Cardiovascular Disease — Payments: $6,852
Dr. Jeffrey Berman, M.d, M.D
Cardiovascular Disease — Payments: $3,299